From: Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Disease | Down-regulated | Up-regulated | AUC | Sensitivity (%) | Specificity (%) | Specimens | Species | References |
---|---|---|---|---|---|---|---|---|
AD | APOC3, APOH, C4BPα, CO3, KV230 | AACT, CO9, IGHM, K2C6A | – | – | – | Serum EVs | Human | [172] |
AD | miR-342-3p, miR-23b-3p, miR-24-3p, miR-125b-5p | miR-141-3p, miR-342-5p | 0.919 | 81.7 | – | Serum EVs | Human | [174] |
AD | BACE-1-AS-LncRNA (in Pre-AD) | BACE-1-AS-LncRNA (in late AD) | – | 75 (pre-AD) 68 (late-AD) | 100 100 | Plasma EVs | Human | [177] |
AD | miR-135a, miR-384 | miR-193b | – | 99 | 95 | Plasma EVs | Human | [175] |
AD | miR-138-5p, miR-342-3p | miR-29c-5p, miR-143-3p, miR-335-5p, miR-485-5p | 0.880 | – | – | Serum EVs | Human | [176] |
AD | – | Aβ42/40 miR-384 | 0.973 0.909 | – | – | Blood NCAM+ NDEVs | Human | [178] |
AD | – | miR-29c-3p | 0.927 |  |  | Blood NCAM+ NDEVs | Human | [179] |
AD | miR-212 miR-132 | – | 0.84 0.77 | 92.2 | 69 | Blood L1CAM+ NDEVs | Human | [180] |
AD | – | tau, p-T181-tau, p-S396-tau, Aβ1−42 | 0.99 | 96 |  | Blood L1CAM+ NDEVs | Human | [181] |
PD | – | α-synuclein | 0.724 | 76.8 | 53.5 | Plasma EVs | Mouse | [183] |
PD | Prp | – | – | – | – | Plasma EVs | Human | [184] |
PD | miR-1 miR-19b-3p | miR-153, miR-409-3p miR-10a-5p let-7 g-3p | 0.920 0.705 0.990 0.900 | – | – | CSF EVs | Human | [185] |
PD | – | α-synuclein, clusterin | 0.98 (PD VS. atypical PD) | – | – | Serum EVs | Human | [119] |
PD | α-synuclein (in PD VS. MSA) |  | 0.902 PD VS. MSA) | – | – | Blood MOG+ ODEVs, L1CAM+ NDEVs | Human | [136] |
ALS | – | CORO1A | – | – | – | Plasma EVs | Human | [186] |
ALS | – | TDP-43, NFL | – | – | – | Plasma EVs | Human | [187] |
ALS | miR-146a-5p | – | – | – | – | CSF EVs | Human | [189] |
ALS | – | miR-15a-5p miR-193a-5p | 0.976 0.844 | 92.9 80.0 | 91.7 88.9 | Plasma EVs | Human | [190] |
ALS | miR-10b-5p miR-29b-3p | miR-146-5p miR-199a-3p, miR-199a-5p miR-151a-3p, miR-151a-5p | – | – | – | Plasma L1CAM+ NDEVs | Human | [191] |